India's plan to bring in a law to ensure doctors prescribe medicines only by their generic names risks proliferating the sale of substandard drugs in a country where regulation is already lax, doctors and pharmaceutical executives say. Prime Minister Narendra Modi said last month that the government was looking at such a law to improve affordability of medicines in the country of 1.2 billion people, where the majority live on less than $2 a day. The government has not given any details or timeframe for the planned legislation but some in the industry fear that hasty execution could harm, not help, public health. Large drugmakers in India that mostly sell generic drugs under their own brand name, or 'branded generics', compete with much smaller garage manufacturers, many of which operate with scant quality checks.

Get updates in Intraday Stocks News and more click here and have your two days Free Trial >> http://www.ripplesadvisory.com/nifty-future-.php